Mike Hollan

This is the latest approval for Phathom Pharmaceutical’s GI treatment.

The tech company’s data platform will be implemented into the genomic research department’s workflow.

The network includes organizations that represent over 45,000 agents and brokers.

Ripston discusses the Biospecimen Management Consortium and how its working to develop best practices for driving sample excellence.

The two companies will use Astrana’s technology offerings to improve access.

EVERSANA’s senior vice president of innovation discusses how the technology has been implemented in various areas of the pharmaceutical industry.

The global president of endomechanical and energy for Johnson & Johnson MedTech discusses the need for multidisciplinary care when treating obesity.

Empara’s virtual assistant is the latest attempt to use AI to simplify the user experience in the healthcare industry.

The AscellaHealth CEO discusses how new technologies are increasing the options in patient care.

The CEO of Revelation Pharma discusses how compounding pharmacies may help solve the ongoing issue with drug shortages.

Dr. Varshney discusses how AI is being used to sort data and discover new molecules and indications for existing drugs.

The compounding pharmacy acquired Taylors Pharmacy and Key Compounding Pharmacy.

Body Vision’s AI-powered LungVision image system earned a place in Vizient’s innovative technology program.

The company announced that it had received certification from BSI Medical Devices.

MTX325 is in Phase I trials and is believed to be able to modify the course of the disease.

The platform is similar to other recent digital platforms in that it is designed to reduce drug costs.

The company announced that it has partnered with Adena Health and The Ohio State University Health Plan Solutions.

Patients who received PrimeC reportedly saw significant impact to the disease’s progression.

As previously announced, Michael assumed the role on July 1.

The platform utilizes standards set forth in a recently published document from the CDC.

AbbVie will add CEL383 to its pipeline.

UltraSight will join the AI marketplace.

The guidance is aimed at helping sponsors recruit test populations that accurately represent real world populations.

Veeva’s vice president of global business consulting discusses recent trends in HCP access and how the pharma industry is reacting.

Rademacher continues his discussion of developing vaccines for outbreaks before they occur.

The company announced that this would reduce instances of interruptions during patient interactions.

A study detailing how patients struggling with obesity interact with the life sciences industry suggests that they don’t get weight loss information from their doctors.

The insurance brokerage firm acquired company’s in Pennsylvania, North Carolina, Mississippi, and Iowa.

The former Bill and Melinda Gates MRI CEO discusses the importance of not-for-profits in developing desperately needed medicines.

The online program is required for brokers and agents to sell Medicare Advantage Plans.